Liaoning Chengda Biological Co., Ltd was established in June 2002. The company adhere to the concept of “face to life, only responsibility”, dedicating to the R&D production and promotion of “international level; domestic leading” biological products. The main products are human rabies vaccine and inactive vaccinium encephalitis epidemic.

        The company has built workshops for vaccine stock solution and vaccine fillings. All the workshops that have been put into production have passed the national new version of GMP certification, and another factory is built in Benxi as a production base for some new varieties. Chengda has maintained a leading position in domestic human rabies vaccine industry.  The products are sold to more than 30 countries and regions.

        In the future, the company will continue to adhere to the innovative and sustainable development strategy of innovation-driven, product-led, professionalization as a guarantee, and efficiency to win, will put people's health first & strictly control product quality, and continue to improve social responsibility management, and focus on people. In the field of vaccines, build intelligent workshops, improve production efficiency, and continue to develop innovative products, strive to contribute to the development of China's biological products industry, and implement national innovation and high-quality development strategies.